Application 125427

Type
BLA
Sponsor
GENENTECH

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001KADCYLAADO-TRASTUZUMAB EMTANSINEVIAL; SINGLE-USE100MGNoNo
002KADCYLAADO-TRASTUZUMAB EMTANSINEVIAL; SINGLE-USE160MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
50242-087KADCYLAADO-TRASTUZUMAB EMTANSINEGenentech, Inc.BLACurrent
50242-087KADCYLAADO-TRASTUZUMAB EMTANSINEGenentech, Inc.BLACurrent
50242-087KADCYLAADO-TRASTUZUMAB EMTANSINEGenentech, Inc.BLACurrent
50242-087KADCYLAADO-TRASTUZUMAB EMTANSINEGenentech, Inc.BLACurrent
50242-087KADCYLAADO-TRASTUZUMAB EMTANSINEGenentech, Inc.BLACurrent
50242-087KADCYLAADO-TRASTUZUMAB EMTANSINEGenentech, Inc.BLACurrent
50242-087KADCYLAADO-TRASTUZUMAB EMTANSINEGenentech, Inc.BLACurrent
50242-088KADCYLAADO-TRASTUZUMAB EMTANSINEGenentech, Inc.BLACurrent
50242-088KADCYLAADO-TRASTUZUMAB EMTANSINEGenentech, Inc.BLACurrent
50242-088KADCYLAADO-TRASTUZUMAB EMTANSINEGenentech, Inc.BLACurrent
50242-088KADCYLAADO-TRASTUZUMAB EMTANSINEGenentech, Inc.BLACurrent
50242-088KADCYLAADO-TRASTUZUMAB EMTANSINEGenentech, Inc.BLACurrent
50242-088KADCYLAADO-TRASTUZUMAB EMTANSINEGenentech, Inc.BLACurrent
50242-088KADCYLAADO-TRASTUZUMAB EMTANSINEGenentech, Inc.BLACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85588SUPPL 2026-03-30
85562SUPPL 2026-03-30
82301SUPPL 2025-05-23
82241SUPPL 2025-05-14
70070SUPPL2022-02-04
70064SUPPL2022-02-03
64748SUPPL2020-09-29
64734SUPPL2020-09-29
58578SUPPL2019-05-06
58560SUPPL2019-05-03
56925SUPPL2018-12-21
56905SUPPL2018-12-20
56004SUPPL2018-10-17
55732SUPPL2018-10-01
39964SUPPL2016-07-27
31969SUPPL2016-07-26
9750SUPPL2016-05-02
39963SUPPL2016-04-29
39962SUPPL2015-06-04
9749SUPPL2015-06-02
39961SUPPL2014-07-15
31968SUPPL2014-07-15
23953ORIG2014-02-07
9748SUPPL2013-09-03
18914SUPPL2013-08-30
9747SUPPL2013-08-22
39960SUPPL2013-08-21
22809ORIG2013-02-28
31967ORIG2013-02-22
24370ORIG2013-02-22
18913ORIG2013-02-22